Skip to Content

Join the 'Cymbalta' group to help and get support from people like you.

Cymbalta News (Page 4)

1 in 13 Young Adults in U.S. Considered Suicide in Past Year

Posted 16 Jun 2016 by

THURSDAY, June 16, 2016 – About one in 13 young adults in the United States had serious thoughts of suicide in 2013-2014, federal officials reported Thursday. That rate of 7.4 percent translates into 2.6 million Americans between the ages of 18 and 25, researchers said. "Suicide is one of the leading causes of death among young adults, and it is preventable," said Kana Enomoto. She's principal...

Antidepressants Not Just for Depression Any More

Posted 24 May 2016 by

TUESDAY, May 24, 2016 – Doctors prescribe antidepressants for a wide range of medical problems other than depression, apparently fueling the boom in sales of these medications, researchers report. Depression accounts for only a little more than half the antidepressant prescriptions issued by Quebec physicians during the past decade, the Canadian study found. Doctors also issued antidepressants...

FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain

Posted 5 Nov 2010 by

Indications include osteoarthritis, chronic lower back pain ROCKVILLE, Md., Nov. 4, 2010--The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.  “Up to three quarters of the population ex...

FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder

Posted 2 Dec 2009 by

INDIANAPOLIS, Nov 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ – The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, Eli Lilly and Company announced today. "Since generalized anxiety disorder can be a chronic illness, it is important that doctors and their patients find a...

FDA Medwatch Alert: Cymbalta (duloxetine hydrochloride) - Oct 17, 2005

Posted 17 Oct 2005 by

[Posted 10/17/2005] Eli Lilly and FDA notified healthcare professionals of revision to the PRECAUTIONS/Hepatotoxicity section of the prescribing information for Cymbalta (duloxetine hydrochloride), indicated for treatment of major depressive disorder and diabetic peripheral neuropathic pain. Postmarketing reports of hepatic injury (including hepatitis and cholestatic jaundice) suggest that...

FDA Medwatch Alert: Cymbalta (duloxetine hydrochloride) - Jul 8, 2005

Posted 8 Jul 2005 by

[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject of a June 30, 2005 Public Health Advisory issued about the risk of suicidality (suicidal thinking or behavior) in adults being treated with antidepressant medications.[Posted 07/01/2005] In response...

FDA Medwatch Alert: Antidepressant Medication Products

Posted 2 May 2007 by

[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information for their products to include warnings about the increased risks of suicidal thinking and behavior in young adults ages 18 to 24 years old during the first one to two months of treatment. The proposed...

FDA Medwatch Alert: Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) - Serotonin Syndrome

Posted 19 Jul 2006 by

[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types of antidepressant and mood disorder medications (selective serotonin reuptake inhibitors (SSRIs) and selective serotonin/norepinephrine reuptake inhibitors (SNRIs). A life-threatening condition called...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Pain, Fibromyalgia, Anxiety, Back Pain, Depression, Diabetic Neuropathy, Diabetic Nerve Damage, Generalized Anxiety Disorder, Major Depressive Disorder, Osteoarthritis

Cymbalta Patient Information at